Transforming Medical and Healthcare
The health care ecosystem is going through a rapid transformation like never before. The medical science and clinical world is seeing concepts like Personalized Medicine, Precision Medicine and Regenerative Medicine rapidly becoming reality. DiponEd Institute of Regenerative Medicine (DIRM) is committed to update the knowledge of the busy practitioners through a mix of compact accessible education program using virtual online and AR VR like platforms plus on-site lab and clinical trainings. DIRM also aims at creating basic medical and scientific level awareness, and skill development on latest personalized health care technologies and treatments through its Participatory Medicine program. Our education program is aimed at advancing healthcare and medical sciences, while integrating latest knowledge from genetics, cellular biology, 3D printing, tissue engineering, proteomics, metabolomics, stem cell transplants, cancer immunotherapies, neoantigens, pharmacogenomics etc.
At DIRM www.diponed.com we offer National & International University affiliated courses in Regenerative medicine and Personalized medicine to qualified surgeons / physicians. It has a very informative coverage on basics of transfusion and transplantation of human stem cells and other subject areas required for developing and running smart health care and personalized medicine, clinics
The institute is also offering skill development in Paramedical, Nursing, Medical lab technology, Clinical Research, IVF and laboratory QA/ QC, Diagnostics lab services etc. DIRM is the beginning of our journey in social health care awareness and medical educationand we aim at transforming it into a modern medical research university
About Translational and Regenerative Medicine
Regenerative medicine is one of the newest and most powerful approaches in biomedical science. It offers the opportunity to experimentally address previously intractable biological questions and develop cell-based therapeutics. It represents the evolution of new treatment options for many unmet medical conditions and illnesses through tissue repair and replacement.
The use of various adult cells and stem cells harvested from patients themselves is demonstrating extremely promising results in clinical trials and other studies. Referred to as stem-cell therapies or cellular therapies, these treatments involve extracting stem cells from the body, isolating and culturing them, and then reintroducing them into the body to induce tissue regeneration.
Many years of hard work and research are bearing fruit as clinical trials progress globally. We can be optimistic that novel therapies will soon make currently untreatable diseases and disorders manageable. It is crucial for clinicians to stay updated on the latest developments in 3D printing, tissue engineering, and cellular transplants, as well as their clinical implications, to prepare for the next generation of healthcare.
CLINICAL AREAS OR REGENERATIVE MEDICINE PRACTICE
Researchers hope stem cells will one day be effective in the treatment of several medical conditions and diseases. But unproven stem cell treatments can be unsafe—so doctors and patients must get all of the facts before considering offering any treatment. Stem cells have been called everything from cure-alls to miracle treatments. DIRM offers to clear the hype through clinical and scientific updates and educating the stake holders of this field.
Regenerative medicine has the potential to heal tissues and organs damaged by age, disease, or trauma, congenital defects etc. Recent preclinical and clinical data supports the possibility for treating both chronic diseases and acute insults, and abet maladies occurring across a wide array of indications in blood related diseases and disorders, including non-healing dermal wounds, diabetes, auto-immune conditions, infectious diseases, pulmonary diseases, male –, female- infertility, neuro- , ortho- , cartilagedegenerative conditions, cardiovascular diseases and traumas, treatments for certain types of cancer, and many more. The current therapy of transplantation of intact organs and tissues to treat organ and tissue failures and loss suffers from limited donor supply and often severe immune complications, but these obstacles may potentially be bypassed through the use of regenerative medicine strategies.
The Indian Council of Medical Research (ICMR), approves the use of minimally manipulated stem cells and hematopoietic stem cells in Blood Related diseases and disorders. Products and procedures like Matrix-inducedAutologusCondrocyte implants MACI , and CAR T cells and Car NK cells like cellular products have got approved by FDAs and the clinicians and laboratory scientists need.
